Generic pharmaceutical company Actavis has launched 29 new products in Bulgaria during the first three months of the year.
The company plans to launch a total of 43 new products in Bulgaria during 2008.
The newly launched products include Fosinopril HCT (cardiovascular) and Lisinopril HCT (cardiovascular), both of which were first to market in Bulgaria.
Actavis also released Sertraline (antidepressant), Bicalutamide (oncology) and Irinotecan (oncology), which has also recently marketed in the US.
Of the 29 products, 23 are nutritional supplements (ActaVit® vitamins; Doctor Mom and ActaStyle dietary supplements) and products from the Decubal cosmetics line.
Actavis is a leading generic pharmaceutical company which specialises in the development, manufacture and sale of generic pharmaceuticals. Based in Iceland, the company has operations in 40 countries and 11,000 employees.
For more information on Actavis in Bulgaria visit www.actavis.bg
Bristol, UK – July 9, 2025 – At this year’s Marketing Confex in Bristol, AI…
Memphis, Tennessee – May 30, 2025 – Future Electronics, a global leader in electronic components,…
London, UK – 1 June 2025 – In a game-changing move for the food-tech and…
Texas, USA – June 2, 2025 – Swift Broadband TV, a leading digital platform for internet…
Oslo, Norway, 07.05.2025 - Fresh off its beta launch, Norwegian AI growth platform Aida made…
Oslo, Norway. 31st March 2025 - Aida Social, an innovator in AI-driven social media content…
